A research to detect potential biomarkers in blood samples from patients with glioma.

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200066658

Enrollment

Unknown

Registered

2022-12-13

Start date

2022-12-15

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

Patients with glioma:N/A

Healthy control group:N/A

Eligibility

Sex/Gender

All

Age

20 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Blood test results are available 2.Comprehensive basic information 3.Blood samples from patients who were diagnosed with glioma according to The People's Republic of China health departmentd diagnostic criteria of gliom.

Exclusion criteria

Exclusion criteria: 1. Incomplete clinical data; 2. Unable to cooperate with biological specimen collection; 3.Others who are not suitable to participate in the clinical trial as judged by the investigator.

Design outcomes

Primary

Measure	Time frame
biomarkers;	—

Countries

China

Contacts

Public ContactGuangwei Wang

Hunan University of Medicine

1815670585@qq.com15367841648

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026